Manulife (Manufacturers Life Insurance)’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $69K | Sell |
25,740
-3,955
| -13% | -$10.6K | ﹤0.01% | 2837 |
|
|
2025
Q1 | $41.9K | Buy |
29,695
+1,107
| +4% | +$1.56K | ﹤0.01% | 2851 |
|
|
2024
Q4 | $56.9K | Buy |
28,588
+2,757
| +11% | +$5.49K | ﹤0.01% | 2923 |
|
|
2024
Q3 | $81.4K | Sell |
25,831
-1,107
| -4% | -$3.49K | ﹤0.01% | 2910 |
|
|
2024
Q2 | $85.1K | Buy |
+26,938
| New | +$85.1K | ﹤0.01% | 2864 |
|
|
2023
Q3 | – | Sell |
-146,566
| Closed | -$315K | – | 2975 |
|
|
2023
Q2 | $315K | Hold |
146,566
| – | – | ﹤0.01% | 2325 |
|
|
2023
Q1 | $286K | Buy |
146,566
+68,821
| +89% | +$134K | ﹤0.01% | 2331 |
|
|
2022
Q4 | $295K | Hold |
77,745
| – | – | ﹤0.01% | 2320 |
|
|
2022
Q3 | $380K | Hold |
77,745
| – | – | ﹤0.01% | 2150 |
|
|
2022
Q2 | $606K | Buy |
77,745
+13,343
| +21% | +$104K | ﹤0.01% | 1911 |
|
|
2022
Q1 | $952K | Buy |
+64,402
| New | +$952K | ﹤0.01% | 1784 |
|